What Diagnostic Safety Protocols Should Practitioners Follow Before Treating Epidermal Lentigines With Aesthetic Laser Or Ipl Systems? Essential Steps To Ensure Safe And Effective Treatment.

Before treating an epidermal lentigine with a laser or IPL system, practitioners must first establish that the lesion is benign. Clinical examination, dermoscopy, and comparison with prior images should be used to identify features suspicious for lentigo maligna, melanoma, or another pigmented lesion. Any lesion that is new, changing, irregular, symptomatic, diagnostically uncertain, or partly amelanotic should be referred for medical assessment and should not be treated cosmetically.

Diagnosis is the primary safety protocol. Laser and IPL can lighten visible melanin without addressing an amelanotic or malignant component, potentially creating incomplete clearance and delaying diagnosis. Treat only lesions that have been clinically confirmed as suitable for energy-based treatment.

Establish That Treatment Is Appropriate

Examine the lesion before using energy

Assess each lesion for asymmetry, irregular borders, color variation, rapid change, ulceration, bleeding, inflammation, or other atypical features. Dermoscopy and baseline photography can improve documentation and help distinguish stable benign lentigines from lesions requiring further evaluation.

A lesion that cannot be confidently classified as a benign solar lentigine or ephelis should not be treated with laser or IPL. Arrange dermatological review and biopsy when clinically indicated.

Consider amelanotic components

Malignant pigmented lesions may contain areas with little or no visible melanin. These areas may not respond to selective photothermolysis, while the pigmented portions may lighten and make the lesion appear deceptively improved.

This is a central limitation of cosmetic light treatment: clearance does not prove benignity. Persistent, atypical, or partially responsive areas require reassessment rather than repeated treatment.

Document the baseline

Take standardized pre-treatment photographs, including an overview and close-up view of the lesion. Record the diagnosis or clinical rationale, lesion location, skin phototype, recent tanning, relevant medications, device, wavelength, fluence, pulse duration, spot size, cooling method, and treatment response.

Obtain informed consent that explains expected clearance, the possibility of multiple sessions, recurrence from ultraviolet exposure, pigmentary complications, burns, scarring, and the need for future surveillance.

Screen the Patient and Treatment Area

Assess skin phototype and recent sun exposure

Determine the patient’s Fitzpatrick skin type and ask about recent tanning, sunburn, self-tanner, and planned sun exposure. Epidermal melanin competes with the target pigment for light absorption, increasing the risk of burns, post-inflammatory hyperpigmentation, hypopigmentation, and dyschromia, particularly in phototypes IV–VI or recently tanned skin.

Defer treatment when the skin is sunburned, recently tanned, or otherwise unstable. Provide strict ultraviolet-avoidance instructions before, during, and after the treatment course.

Review medications and photosensitivity

Ask specifically about photosensitizing drugs, topical agents, systemic retinoids, recent isotretinoin use, and medications that may alter wound healing or pigmentation. Examples of potentially relevant agents include tetracyclines, sulfonamides, 5-fluorouracil, tretinoin, and isotretinoin.

Do not instruct patients to stop prescribed medication automatically. Follow the device labeling and local protocol, and obtain clearance from the prescribing clinician when a medication may increase photosensitivity or treatment risk.

Inspect for contraindications and hazards

Do not treat over suspicious or undiagnosed pigmented lesions, active infection, open wounds, significant dermatitis, or recently irritated skin. Examine the area for tattoos, permanent makeup, cosmetic pigments, and products that could absorb energy or ignite.

Maintain a clear safety margin of at least 1 cm around tattoos or semi-permanent makeup, unless the device manufacturer provides a more conservative requirement. Direct exposure can cause blistering, burns, scarring, or pigment color changes.

Prepare the Room and Skin Safely

Remove flammable and light-absorbing products

Clean the treatment area thoroughly to remove makeup, moisturizers, oils, deodorants, self-tanner, and other residues. If an alcohol-based disinfectant is used, allow it to evaporate completely before firing the device.

Residual alcohol or other flammable liquids can ignite under high-energy laser exposure. The treatment field should be visibly dry, clean, and free of unnecessary products.

Protect every person in the room

Use protective eyewear matched to the specific wavelength and device. Eye protection is required for the patient, practitioner, and every other person who remains in the treatment room.

Extra caution is required near the eyes. Never operate within the bony orbit without appropriate protection, and use properly fitted external or intraocular metal shields when the treatment location and device protocol require them.

Verify the equipment and treatment parameters

Confirm the device wavelength, handpiece, pulse mode, spot size, fluence, and cooling system before treatment. Parameters should be based on the patient’s skin type, lesion depth, pigment characteristics, recent sun exposure, and the manufacturer’s instructions.

Do not transfer settings directly between different machines. Apparent equivalence between devices is unreliable because pulse structures, beam profiles, cooling systems, and calibration can differ.

Use a Controlled Treatment Protocol

Select the wavelength for the target and skin

Shorter-wavelength systems, such as 532 nm Q-switched Nd:YAG, and pigment-selective systems such as 755 nm Alexandrite may target superficial melanin in appropriately selected light-skinned patients. Broad-spectrum IPL can also treat benign superficial lentigines when the diagnosis and patient selection are appropriate.

For darker skin phototypes, longer-wavelength approaches may reduce epidermal melanin absorption, but they do not eliminate risk. Device selection, conservative fluence, pulse parameters, and effective epidermal cooling remain essential.

Perform a test spot when risk is significant

Use a test spot with delayed assessment when the patient has a darker phototype, recent tanning, a history of pigmentary complications, or uncertain tissue response. Evaluate the reaction according to the device protocol before treating the full lesion.

Immediate whitening or darkening can be expected with some pigment treatments, but excessive pain, gray or white epidermal change, blistering, or other signs of thermal injury require stopping and reassessing.

Protect the epidermis with cooling

Use the cooling system appropriate to the device, such as contact cooling, forced cold air, chilled gel where permitted, or dynamic cryogen cooling. Cooling helps reduce nonspecific epidermal heating from scattered light and competitive absorption by epidermal melanin.

Monitor the skin continuously rather than relying only on preset values. Adjust fluence, pulse structure, repetition rate, and cooling in response to real-time tissue reaction and the manufacturer’s guidance.

Plan for staged clearance

Benign lentigines may require one to three sessions, but the number of treatments should not be predetermined at the expense of diagnostic caution. Allow appropriate healing and reassess the lesion between sessions.

A lesion that fails to respond, responds unevenly, or develops new suspicious characteristics should be referred for medical evaluation instead of receiving progressively higher energy.

Understanding the Trade-offs

Cosmetic improvement can obscure clinical change

Lightening a lesion may make future comparison more difficult, particularly if the original photographs are poor or the diagnosis was uncertain. Baseline images and precise treatment records are therefore part of the safety process, not administrative extras.

Patients should understand that treatment does not remove the need for routine skin surveillance. New or changing lesions elsewhere, or recurrence within a treated site, should be medically assessed.

Higher energy is not automatically better

Increasing fluence may improve pigment disruption but also raises the risk of burns, scarring, prolonged erythema, and permanent dyspigmentation. Device settings must be titrated to the patient and lesion rather than selected solely to achieve rapid visible darkening or clearance.

Recurrence remains possible

Ultraviolet exposure can stimulate new pigment and contribute to recurrence. Prescribe broad-spectrum sunscreen, sun avoidance, protective clothing, and ongoing photoprotection after treatment.

IPL requires particular diagnostic discipline

IPL uses a broad range of wavelengths and is less selective than a narrowly targeted laser. That makes careful diagnosis, conservative parameter selection, cooling, and protection of surrounding pigmented structures especially important.

Making the Right Choice for Your Goal

The safest protocol begins with diagnosis and continues through documentation, parameter selection, eye protection, cooling, and follow-up.

If your primary focus is diagnostic safety: Treat only lesions confidently identified as benign, and refer any atypical, changing, amelanotic, or uncertain lesion for dermatological assessment before treatment.
If your primary focus is preventing pigmentary complications: Assess skin phototype and tanning, defer treatment on recently tanned skin, use conservative parameters, perform a test spot when appropriate, and apply effective epidermal cooling.
If your primary focus is ocular and fire safety: Use wavelength-specific eye protection for everyone in the room, use appropriate shields near the orbit, and ensure all alcohol-based products have fully evaporated.
If your primary focus is treatment effectiveness: Match the wavelength and device to superficial melanin and patient characteristics, reassess between sessions, and do not escalate energy when incomplete response may indicate a diagnostic problem.
If your primary focus is long-term results: Provide strict ultraviolet-avoidance and broad-spectrum sunscreen advice, document the treated lesion, and maintain surveillance for recurrence or new suspicious changes.

Aesthetic laser or IPL treatment is appropriate only after the lesion, patient, environment, and treatment parameters have all been assessed as safe.

Summary Table:

Safety Protocol	Key Points
Diagnosis	Confirm lesion is benign (clinical exam, dermoscopy, history). Refer suspicious lesions.
Patient Screening	Assess skin type, sun exposure, medications, contraindications.
Skin Preparation	Clean area, remove flammable products, allow alcohol dry.
Eye Protection	Protect patient, practitioner, and observers with wavelength-specific eyewear.
Equipment Check	Verify settings, test spot for high-risk cases.
Cooling	Use appropriate cooling to minimize epidermal damage.
Follow-up	Document baseline, monitor response, plan repeated sessions as needed.

Ensure safe and effective aesthetic treatments with BELIS. Our advanced laser and IPL systems include built-in safety features and comprehensive protocols to support your practice. Contact us today to learn how our devices can enhance diagnostic confidence and treatment outcomes for your clinic or premium salon.